Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent developments in insulin delivery techniques. Current status and future potential.

F P Kennedy1

  • 1Department of Endocrinology and Internal Medicine, Mayo Clinic, Rochester, Minnesota.

Drugs
|August 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimisation of the management of patients with coronary heart disease and type 2 diabetes mellitus.

Drugs & aging·2001
Same author

Effects of pulsatile intravenous insulin therapy on the progression of diabetic nephropathy.

Metabolism: clinical and experimental·2000
Same author

Prospective evaluation of Roux-en-Y gastric bypass as primary operation for medically complicated obesity.

Mayo Clinic proceedings·2000
Same author

Malabsorptive procedures for severe obesity: comparison of pancreaticobiliary bypass and very very long limb Roux-en-Y gastric bypass.

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract·1999
Same author

Relationship between autonomic function and progression of renal disease in diabetic proteinuria: clinical correlations and implications for blood pressure control.

American journal of hypertension·1998
Same author

A practical guideline for management of hypertension in patients with diabetes.

Mayo Clinic proceedings·1996
Same journal

Botulinum Toxin Type A for Trigeminal and Postherpetic Neuralgia: An Umbrella Review of Systematic Reviews.

Drugs·2026
Same journal

Biologics and Small Molecule Inhibitors: Novel Therapeutic Strategies for Cutaneous Adverse Drug Reactions.

Drugs·2026
Same journal

Use of Sedative-Hypnotic Drugs and the Risk of Developing Alzheimer's Disease: A Systematic Review, Meta-Analysis and Meta-Regression.

Drugs·2026
Same journal

Relacorilant: First Approval.

Drugs·2026
Same journal

Developmental Progress and Future Potential for Inhaled Biologics in the Treatment of Respiratory Diseases.

Drugs·2026
Same journal

Linerixibat: First Approval.

Drugs·2026
See all related articles

Exploring advanced insulin delivery methods beyond injections, this research highlights innovations like pumps, transplantation, and novel delivery systems. The goal is to achieve better glycemic control and reduce diabetes complications.

Area of Science:

  • Endocrinology
  • Biomedical Engineering
  • Pharmacology

Background:

  • Subcutaneous insulin injections are standard but have limitations.
  • Current methods aim for more physiological insulin delivery to improve glycemic control.
  • Diabetes mellitus complications remain a significant concern.

Purpose of the Study:

  • To review current and emerging insulin delivery technologies.
  • To assess their potential for improving glycemic control and reducing diabetes complications.
  • To identify the challenges and future directions in insulin therapy.

Main Methods:

  • Review of various insulin delivery systems including pumps, transplantation, and novel formulations.
  • Analysis of their impact on glycemic control and complication rates.

Related Experiment Videos

  • Discussion of emerging technologies like glucose sensors and insulin analogues.

    • Main Results:

    • Multiple daily injections and continuous subcutaneous insulin infusion pumps improve glycemic control.
    • Pancreas and islet cell transplantation show promise but require immunosuppression.
    • Emerging methods like oral, nasal, and transdermal delivery, as well as biohybrid artificial pancreases, are under development.

    Conclusions:

    • While significant progress has been made, the ideal insulin delivery method is yet to be developed.
    • Future advancements in glucose sensing and insulin analogue synthesis hold promise for improved diabetes management.
    • Balancing efficacy, safety, and patient convenience remains a key challenge.